org placeholder image

Charles Dorsey

Director of Diagnostics at Aytu BioPharma

  • LinkedIn

Email Email: c****@aytubio.com

phone noPhone Number: (***)-***-****

map
AYTU BIOPHARMA

AYTU BIOPHARMA

  • description Description
    Aytu BioPharma (NASDAQ: AYTU) is a dynamic specialty pharmaceutical company with a growing commercial portfolio of prescription medicines addressing complex conditions, with a focus on ADHD a...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Aytu BioPharma Org Chart and Mapping

Employees

Joe Cappello

Vice President, Trade & Market Access

Kunj Samani

Engineering and Maintenance Manager

Eli Gingerich

Corporate Accountant - Consumer Health

Chance Henke

Pharmaceutical Sales Specialist

Sarah Foster

Independent Human Resources Consultant

Sergiy Ivanov

Manager Brand Retail Operations

Sabrina B

Accounts Payable Associate

Frequently Asked Questions Regarding Charles Dorsey

Answer: Charles Dorsey works for Aytu BioPharma as Director of Diagnostics

Answer: Charles Dorsey’s role in Aytu BioPharma is Director of Diagnostics

Answer: Charles Dorsey's email address is c***@gmail.com

Answer: Charles Dorsey's business email address is c****@aytubio.com

Answer: Charles Dorsey’s direct phone number is (***)-***-****

Answer: Charles Dorsey works in the industry of: Pharmaceuticals

Answer: Charles Dorsey works Aytu BioPharma located at 373 Inverness Parkway, Denver, Colorado, 80112, United States

Answer: Aytu BioPharma's Director of Diagnostics is Charles Dorsey

Answer: Charles Dorsey contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@aytubio.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access